EE05185B1 - Kompositsioonid p?letikuliste protsesside k„sitlemiseks - Google Patents

Kompositsioonid p?letikuliste protsesside k„sitlemiseks

Info

Publication number
EE05185B1
EE05185B1 EEP200100397A EEP200100397A EE05185B1 EE 05185 B1 EE05185 B1 EE 05185B1 EE P200100397 A EEP200100397 A EE P200100397A EE P200100397 A EEP200100397 A EE P200100397A EE 05185 B1 EE05185 B1 EE 05185B1
Authority
EE
Estonia
Prior art keywords
handling
compositions
inflammatory processes
inflammatory
processes
Prior art date
Application number
EEP200100397A
Other languages
English (en)
Estonian (et)
Inventor
M. Linden Joel
W. Sullivan Gail
J. Sarembock Ian
Macdonald Timothy
Okusa Mark
L. Kron Irving
Michael Scheld W.
Original Assignee
University Of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/333,387 external-priority patent/US6232297B1/en
Application filed by University Of Virginia Patent Foundation filed Critical University Of Virginia Patent Foundation
Publication of EE200100397A publication Critical patent/EE200100397A/xx
Publication of EE05185B1 publication Critical patent/EE05185B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100397A 1999-02-01 2000-01-31 Kompositsioonid p?letikuliste protsesside k„sitlemiseks EE05185B1 (et)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11802999P 1999-02-01 1999-02-01
US12431699P 1999-03-12 1999-03-12
US13337499P 1999-05-10 1999-05-10
US13557399P 1999-05-24 1999-05-24
US09/333,387 US6232297B1 (en) 1999-02-01 1999-06-15 Methods and compositions for treating inflammatory response
US15141299P 1999-08-30 1999-08-30
PCT/US2000/002324 WO2000044763A2 (en) 1999-02-01 2000-01-31 Compositions for treating inflammatory response

Publications (2)

Publication Number Publication Date
EE200100397A EE200100397A (et) 2002-08-15
EE05185B1 true EE05185B1 (et) 2009-06-15

Family

ID=27557920

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100397A EE05185B1 (et) 1999-02-01 2000-01-31 Kompositsioonid p?letikuliste protsesside k„sitlemiseks

Country Status (26)

Country Link
EP (1) EP1150991B1 (es)
JP (1) JP4837831B2 (es)
KR (1) KR100668006B1 (es)
CN (1) CN1191266C (es)
AR (1) AR029332A1 (es)
AT (1) ATE263777T1 (es)
AU (2) AU778870B2 (es)
BR (1) BR0007864A (es)
CA (1) CA2361614C (es)
CZ (1) CZ296404B6 (es)
DE (1) DE60009665T2 (es)
DK (1) DK1150991T3 (es)
EE (1) EE05185B1 (es)
ES (1) ES2215609T3 (es)
HK (1) HK1047288A1 (es)
HU (1) HU228937B1 (es)
IL (2) IL144188A0 (es)
MX (1) MXPA01007850A (es)
MY (1) MY129445A (es)
NO (1) NO321216B1 (es)
NZ (1) NZ513096A (es)
PL (1) PL199953B1 (es)
PT (1) PT1150991E (es)
SK (1) SK284877B6 (es)
UA (1) UA72912C2 (es)
WO (1) WO2000044763A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US7427606B2 (en) 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
NZ556354A (en) 2001-10-01 2008-10-31 Univ Virginia 2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
CA2563123A1 (en) * 2004-04-02 2005-10-20 Adenosine Therapeutics, Llc Selective antagonists of a2a adenosine receptors
US7396825B2 (en) * 2004-05-03 2008-07-08 University Of Virginia Patent Foundation Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
WO2006028618A1 (en) 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7442687B2 (en) 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7605143B2 (en) 2004-08-02 2009-10-20 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
US8178509B2 (en) 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
WO2007107598A1 (en) 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
BRPI0913939A2 (pt) 2008-07-03 2016-04-26 Univ Virginia Patent Found dose unitária de apadenoson
BRPI1014224A2 (pt) 2009-06-30 2019-09-24 Forest Laboratories Holdings Ltd composto, composição farmacêutica,e, método para tratar um estado.
FR2960876B1 (fr) 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
EP3988560A4 (en) * 2019-06-21 2023-07-26 Academy of Military Medical Sciences SMALL MOLECULAR COMPOUND WITH A2A ADENOSINE RECEPTOR ANTAGONISM

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537228A1 (de) * 1985-10-19 1987-04-23 Huels Chemische Werke Ag Verfahren zur herstellung von cyclohexylverbindungen
JPS6299330A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd 抗高血圧剤
KR0137786B1 (ko) * 1988-11-15 1998-05-15 하마구찌 미찌오 심장 또는 뇌의 허혈성 질환의 치료, 예방제
CA2035038C (en) * 1989-06-20 1998-12-29 Toyofumi Yamaguchi Synthetic intermediates of 2-alkynyladenosines, processes for preparing the synthetic intermediates, processes for preparing 2-alkynyladenosines utilizing the synthetic intermediates, and stable 2-alkynyladenosine derivatives
WO1991009864A1 (en) * 1990-01-04 1991-07-11 Yamasa Shoyu Kabushiki Kaisha Drug for treating or preventing ischemic diseases of heart or brain
JPH03287537A (ja) * 1990-03-31 1991-12-18 Yamasa Shoyu Co Ltd 抗動脈硬化症剤
JP3025559B2 (ja) * 1990-07-19 2000-03-27 ヤマサ醤油株式会社 アデノシン誘導体
JP3025557B2 (ja) * 1991-06-28 2000-03-27 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
JP3053908B2 (ja) * 1991-06-28 2000-06-19 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
WO1998052611A1 (fr) * 1997-05-23 1998-11-26 Nippon Shinyaku Co., Ltd. Preparation medicamenteuse aux fins de la prevention et du traitement des hepatopathies
EP1014995A4 (en) * 1997-06-18 2005-02-16 Aderis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR PREVENTING RESTENOSES CONSECUTIVE TO REVASCULARIZATION INTERVENTIONS
JPH11335302A (ja) * 1998-05-26 1999-12-07 Toa Eiyo Ltd 安定な医薬組成物
JP3619017B2 (ja) * 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物

Also Published As

Publication number Publication date
SK284877B6 (sk) 2006-01-05
AU2005201255A1 (en) 2005-04-21
AU2005201255B2 (en) 2008-02-28
HUP0200224A2 (en) 2002-06-29
BR0007864A (pt) 2001-11-06
AU2745400A (en) 2000-08-18
HU228937B1 (en) 2013-06-28
CA2361614A1 (en) 2000-08-03
AR029332A1 (es) 2003-06-25
MY129445A (en) 2007-04-30
DE60009665D1 (de) 2004-05-13
PT1150991E (pt) 2004-08-31
PL199953B1 (pl) 2008-11-28
DE60009665T2 (de) 2004-08-19
CZ20012781A3 (cs) 2002-01-16
NO20013507D0 (no) 2001-07-13
AU778870B2 (en) 2004-12-23
DK1150991T3 (da) 2004-06-07
IL144188A (en) 2008-12-29
KR100668006B1 (ko) 2007-01-15
EE200100397A (et) 2002-08-15
EP1150991B1 (en) 2004-04-07
EP1150991A2 (en) 2001-11-07
CN1357002A (zh) 2002-07-03
WO2000044763A3 (en) 2000-12-14
IL144188A0 (en) 2002-05-23
WO2000044763A2 (en) 2000-08-03
ES2215609T3 (es) 2004-10-16
HUP0200224A3 (en) 2005-02-28
JP2002536300A (ja) 2002-10-29
MXPA01007850A (es) 2002-08-20
ATE263777T1 (de) 2004-04-15
KR20020013494A (ko) 2002-02-20
CZ296404B6 (cs) 2006-03-15
UA72912C2 (uk) 2005-05-16
CN1191266C (zh) 2005-03-02
NZ513096A (en) 2003-01-31
CA2361614C (en) 2008-08-26
CA2361614E (en) 2000-08-03
NO20013507L (no) 2001-09-18
SK10972001A3 (sk) 2002-01-07
HK1047288A1 (en) 2003-02-14
NO321216B1 (no) 2006-04-03
JP4837831B2 (ja) 2011-12-14

Similar Documents

Publication Publication Date Title
NO2021009I1 (no) XARELTO - forlenget SPC
EE05185B1 (et) Kompositsioonid p?letikuliste protsesside k„sitlemiseks
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
DE60207390D1 (de) Entzündungshemmende benzimidazolverbindungen
AR023440A1 (es) Composiciones antitranspirantes
DE60028268D1 (de) Fluorkautschukzusammensetzungen
IS6120A (is) Lyfjablanda
PT1181017E (pt) Inibidores de metaloproteases
NO20014608L (no) Vekstfremmende sammensetninger
PT1206182E (pt) Composicoes herbicidas
DE60033373D1 (de) Flammgeschützte polyolefinzusammensetzungen
DE69922267D1 (de) Bewegliches zusammensetzspiel
ID29785A (id) Komposisi-komposisi sampo
ATE305470T1 (de) Naphthyridinverbindungen
PT1194404E (pt) Inibidores de aspartil-protease
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE60016868D1 (de) Notrutsche
DE69943245D1 (de) Gaserzeugende zusammensetzung
DE60014955D1 (de) Schraubzange
DE19917146B4 (de) Nullpunktspannsystem
DE60106131D1 (de) Handhabungssystem für Gegenstände
DE60000022D1 (de) Verbesserte teilchenförmige Zusammensetzungen
ID30272A (id) Komposisi resorsinol
DE29907993U1 (de) Gehhilfe für einarmige Handhabung
DE50012945D1 (de) Transportpalette

Legal Events

Date Code Title Description
LD4A Amendment in the specification
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20180131